Dexmedetomidine and Anesthesia.

dc.contributor.authorSharma, Sudivya
dc.contributor.authorJain, Prashast
dc.date.accessioned2017-01-30T05:24:34Z
dc.date.available2017-01-30T05:24:34Z
dc.date.issued2013-08
dc.description.abstractThe α2-adrenoceptors (ARs) by virtue of their sedative, analgesic, sympatholytic, anesthetic-sparing and hemodynamicstabilizing properties, have been used as an adjunct to local anesthetics for prolongation of effect. Dexmedetomidine a stereoisomer of medetomidine a highly selective α2-adrenergic receptor (AR) agonist with a relatively high ratio of α2/ α1-activity (1620:1 as compared to 220:1 for clonidine). It has recently been introduced in anesthesia practice. It is currently being used for continuous intravenous sedation in the intensive care setting and procedural sedation in nonintubated patients.en_US
dc.identifier.citationSharma Sudivya, Jain Prashast. Dexmedetomidine and Anesthesia. Indian Journal of Clinical Practice. 2013 Aug; 24(3): 223-225.en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/182596
dc.language.isoenen_US
dc.source.urihttps://medind.nic.in/iaa/t13/i8/iaat13i8p223.pdfen_US
dc.subjectDexmedetomidineen_US
dc.subjectα2-2 adrenergic receptor agonisten_US
dc.subjectadjuvanten_US
dc.subjectanalgesicen_US
dc.titleDexmedetomidine and Anesthesia.en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ijcp2013v24n3p223.pdf
Size:
314.45 KB
Format:
Adobe Portable Document Format
Description:
Anesthesiology
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: